mCSPC Education: Symptom Management During Treatment of mCSPC
Description
Androgen deprivation therapy (ADT) treatment of metastatic castration-sensitive prostate cancer (mCSPC) can lead to a variety of side effects that may be uncomfortable for patients. In this interactive case study, learners will be introduced to some common side effects of ADT and review management strategies.
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
You will enjoy access for 90 days from date of purchase, after which you will no longer be able to access the course.
Course Topics
- Prostate cancer
- Symptom management
Expected Outcomes
- Learners will report an increase in knowledge related to care of patients receiving treatment for mCSPC.
- Learners will report an increase in confidence in managing side effects of mCSPC treatment.
Target Audience
Oncology nurses and other care providers, including point-of-care, care coordinators, and nurse navigators.
ILNA Breakdown
Up to .75 ILNA points may be applied to Coordination of Care OR Oncology Nursing Practice OR Symptom Management OR Treatment. No more than .75 total points may be claimed for the program.